Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05330767 · ClinicalTrials.gov registry record
DermaClose DUKE Fasciotomy and Wound Study
A clinical trial, sponsored by Baxter Healthcare Corporation.
- Terminated
- Registry status
- 7
- Enrollment target
NCT05330767: Clinical Trial study, sponsored by Baxter Healthcare Corporation.
NCT05330767 is a clinical trial that was terminated before completion, run by Baxter Healthcare Corporation. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05330767 was terminated before completion, sponsored by Baxter Healthcare Corporation.
- TERMINATED
- Registry status
- 7 participants
- Enrollment target
Study Summary
To evaluate the clinical performance of DermaClose and DermaClose XL Continuous External Tissue Expander (CETE) devices to reduce wound size and/or assist with closure in acute full thickness wounds of the skin and assess the need for skin grafting for patients undergoing a four-compartment leg fasciotomy.
Primary Outcome
Wounds may result from four-compartment leg fasciotomies.
Interventions
- DEVICE DermaClose Continuous External Tissue Expander Device
- DEVICE DermaClose XL Continuous External Tissue Expander Device
- DEVICE Conventional wound dressings
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2022-08-22 |
| Est. Completion | 2023-11-13 |
Why NCT05330767 stopped before completion
NCT05330767 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 7 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which DermaClose Continuous External Tissue Expander Device is the first listed.
NCT05330767 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05330767 about?
NCT05330767 is a clinical study titled "DermaClose DUKE Fasciotomy and Wound Study". To evaluate the clinical performance of DermaClose and DermaClose XL Continuous External Tissue Expander (CETE) devices to reduce wound size and/or assist with closure in acute full thickness wounds of the skin and assess the need for skin grafting for patients undergoing a four-compartment leg fasc...
What is the current status of trial NCT05330767?
This trial is currently terminated. The enrollment target is 7 participants. The study started on 2022-08-22. Estimated completion is 2023-11-13.
What interventions are being tested in trial NCT05330767?
The interventions under investigation include: DermaClose Continuous External Tissue Expander Device (DEVICE), DermaClose XL Continuous External Tissue Expander Device (DEVICE), Conventional wound dressings (DEVICE).
Who is sponsoring clinical trial NCT05330767?
This trial is sponsored by Baxter Healthcare Corporation, which has 46 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI